Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma
Binghua Li, Yunzheng Li, Huajun Zhou, et al.
Hepatology (2023) Vol. 79, Iss. 2, pp. 289-306
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Precision treatment in advanced hepatocellular carcinoma
Xupeng Yang, Chen Yang, Shu Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 180-197
Open Access | Times Cited: 124
Metabolic reprogramming in the tumor microenvironment of liver cancer
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 41
Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer
Xinyi Guo, Hu Nie, Wenwen Zhang, et al.
Cancer Cell (2025)
Closed Access | Times Cited: 3
Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy
Zhong-Chen Li, Jie Wang, He-Bin Liu, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113877-113877
Open Access | Times Cited: 5
The switch triggering the invasion process: Lipid metabolism in the metastasis of hepatocellular carcinoma
Jiaqian Zhang, Zhicheng Zhang, Zhangfan Wu, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 11, pp. 1271-1284
Open Access | Times Cited: 4
Integrative analysis of single-cell and bulk RNA sequencing reveals the oncogenic role of ANXA5 in gastric cancer and its association with drug resistance
Denggang Chen, Peng Zhang, Li Gong, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Latent class analysis‐derived classification for cancer‐specific death stratification of hepatocellular carcinoma
Xiaoyan Jiang, Qianyuan Zhang, Zhong Zheng, et al.
International Journal of Cancer (2025)
Closed Access
Integrating single-cell and bulk RNA sequencing data to characterize the heterogeneity of glycan-lipid metabolism polarization in hepatocellular carcinoma
Peng Lin, Qiong Qin, Xiang-Yu Gan, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Application of multi-omics in hepatocellular carcinoma: new prospects for classification and precise diagnosis and treatment
Jiaxue He, Xintong Hu, Liguo Chen, et al.
Hepatoma Research (2025)
Open Access
Plasma lipidomic analysis reveals disruption of ether phosphatidylcholine biosynthesis and facilitates early detection of hepatitis B-related hepatocellular carcinoma
Yuyao Yuan, Di Yin, Xinwei Yang, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
A Multi-Omics-Empowered Framework for Precision Diagnosis and Treatment of Lysosomal Diseases
Nguyen Thi Hai Yen, Nguyen Tran Nam Tien, Nguyen Quang Thu, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101274-101274
Open Access
Targeting NAT10 attenuates homologous recombination via destabilizing DNA:RNA hybrids and overcomes PARP inhibitor resistance in cancers
Zhu Xu, Mingming Zhu, Longpo Geng, et al.
Drug Resistance Updates (2025), pp. 101241-101241
Closed Access
Lipid Metabolism and Immune Response in Hepatocellular Carcinoma: Interplay Driving Tumor Progression
Tiffany Ching-Yun Yu, Yu‐Man Tsui, Xin Zhang, et al.
(2025)
Open Access
Precision medicine and personalized treatment
Harpreet Kaur Channi, Ramandeep Sandhu, Mandeep Kaur, et al.
Elsevier eBooks (2025), pp. 151-174
Closed Access
Advances in Sampling and Analytical Techniques for Single‐Cell Metabolomics: Exploring Cellular Heterogeneity
Xinxin Shen, Fangyuan Zhang, Chunping Tang, et al.
Rapid Communications in Mass Spectrometry (2025) Vol. 39, Iss. 13
Closed Access
Discovery of Genomic Targets and Therapeutic Candidates for Liver Cancer Using Single-Cell RNA Sequencing and Molecular Docking
B.N. Biswas, Masahiro Sugimoto, Md. Aminul Hoque
Biology (2025) Vol. 14, Iss. 4, pp. 431-431
Open Access
Transcriptome Profiling and Viral−Human Interactome Insights Into HBV‐Driven Oncogenic Alterations in Hepatocellular Carcinoma
Ashwin N. Ananthakrishnan, Althaf Mahin, Thottethodi Subrahmanya Keshava Prasad, et al.
Microbiology and Immunology (2025)
Closed Access
Multi-omic analysis reveals a CAF-stemness-governed classification in HCC liver transplant recipients beyond the Milan criteria
Sunbin Ling, Jiong-Jie Yu, Qifan Zhan, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
RBM39 Promotes Base Excision Repair to Facilitate the Progression of HCC by Stabilising OGG1 mRNA
Hongda An, Anliang Xia, Siyuan Liu, et al.
Cell Proliferation (2025)
Open Access
The Role of Metabolic Reprogramming in the Tumor Immune Microenvironment: Mechanisms and Opportunities for Immunotherapy in Hepatocellular Carcinoma
Nan Hu, Haiyang Li, Changcheng Tao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5584-5584
Open Access | Times Cited: 3
The role of metabolic reprogramming in liver cancer and its clinical perspectives
Mengxiao Lu, Yingjie Wu, Min Xia, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Development of Mutated β-catenin Gene Signature to identify CTNNB1 mutations from whole and spatial transcriptomic data in patients with HCC
Brandon M. Lehrich, Junyan Tao, Silvia Liu, et al.
JHEP Reports (2024) Vol. 6, Iss. 12, pp. 101186-101186
Open Access | Times Cited: 2
The prognostic role of ACSL4 in postoperative adjuvant TACE-treated HCC: implications for therapeutic response and mechanistic insights
Feng Ji, Jin-Lian Bin, Xiwen Liao, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Potential crosstalk between Naïve CD4+ T cells and SPP1+ Macrophages is associated with clinical outcome and therapeutic response in hepatocellular carcinoma
Libin Dong, Xun Qiu, Zekuan Li, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113231-113231
Closed Access | Times Cited: 1
Integration of network pharmacology, metabolomics and lipidomics for clarifying the role of sphingolipid metabolism in the treatment of liver cancer by regorafenib
Hua Mu, Jinlong Hu, Zhikun Lin, et al.
Life Sciences (2024) Vol. 358, pp. 123165-123165
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top